Cargando…
Progress in the studies on the molecular mechanisms associated with multidrug resistance in cancers
Chemotherapy is one of the important methods to treat cancer, and the emergence of multidrug resistance (MDR) is one major cause for the failure of cancer chemotherapy. Almost all anti-tumor drugs develop drug resistance over a period of time of application in cancer patients, reducing their effects...
Autores principales: | Zhang, Lei, Ye, Biwei, Chen, Zhuo, Chen, Zhe-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031261/ https://www.ncbi.nlm.nih.gov/pubmed/36970215 http://dx.doi.org/10.1016/j.apsb.2022.10.002 |
Ejemplares similares
-
Ribociclib Inhibits P-gp-Mediated Multidrug Resistance in Human Epidermoid Carcinoma Cells
por: Zhang, Lei, et al.
Publicado: (2022) -
Multidrug resistance associated proteins in multidrug resistance
por: Sodani, Kamlesh, et al.
Publicado: (2012) -
Autophagy and multidrug resistance in cancer
por: Li, Ying-Jie, et al.
Publicado: (2017) -
A Review of Research Progress in Multidrug-Resistance Mechanisms in Gastric Cancer
por: Ruan, Tuo, et al.
Publicado: (2020) -
Current Status on Marine Products with Reversal Effect on Cancer Multidrug Resistance
por: Abraham, Ioana, et al.
Publicado: (2012)